Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction

Br J Haematol. 2024 Nov;205(5):2045-2048. doi: 10.1111/bjh.19737. Epub 2024 Aug 29.

Chenyu Lin^{1

2}, Clare E Anderson^{1

3}, Micaela R Scobie⁴, Thomas D Rodgers^{1

2}, Michael J Kelley^{1

5

6}, Daphne R Friedman^{1

5

6}

¹ Division of Hematology-Oncology, Durham VA Health System, Durham, North Carolina, USA.
² Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina, USA.
³ Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
⁴ National Precision Oncology Program, US Veterans Affairs Administration, Washington, District of Columbia, USA.
⁵ National Oncology Program Office, US Veterans Affairs Administration, Washington, District of Columbia, USA.
⁶ Division of Medical Oncology, Duke University School of Medicine, Durham, North Carolina, USA.

No abstract available

Publication types